These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 8674964

  • 21. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
    Bach MA, Wallach D, Flageul B, Hoffenbach A, Cottenot F.
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
    [Abstract] [Full Text] [Related]

  • 22. Antileprosy drugs, pregnancy and fetal outcome.
    Bhargava P, Kuldeep CM, Mathur NK.
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):457-8. PubMed ID: 9030117
    [No Abstract] [Full Text] [Related]

  • 23. Study of multidrug therapy in paucibacillary leprosy.
    Kar PK, Sohi AS.
    J Indian Med Assoc; 1989 Feb; 87(2):34-6. PubMed ID: 2674283
    [Abstract] [Full Text] [Related]

  • 24. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I, Cartel JL, Grosset JH.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [Abstract] [Full Text] [Related]

  • 25. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS, Scolyer RA, Barnetson RS.
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [Abstract] [Full Text] [Related]

  • 26. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
    Kamal R, Dayal R, Katoch VM, Katoch K.
    Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
    [Abstract] [Full Text] [Related]

  • 27. A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients.
    Shetty VP, Wakade A, Antia NH.
    Lepr Rev; 2001 Sep; 72(3):337-44. PubMed ID: 11715280
    [No Abstract] [Full Text] [Related]

  • 28. Serious side effects of rifampin on the course of WHO/MDT: a case report.
    Namisato M, Ogawa H.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):277-82. PubMed ID: 11221090
    [Abstract] [Full Text] [Related]

  • 29. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
    Pattyn SR, Bourland J, Grillone S, Groenen G, Ghys P.
    Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
    [Abstract] [Full Text] [Related]

  • 30. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G, Janssens L, Kayembe T, Nollet E, Coussens L, Pattyn SR.
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN, Christian M, Jesudasan K, Kurian N, Rao GS.
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [Abstract] [Full Text] [Related]

  • 33. Response of leprosy patients with single lesions to MDT.
    Katoch K, Natrajan M, Yadav VS, Bhatia AS.
    Acta Leprol; 1995 Jun; 9(3):133-7. PubMed ID: 7631584
    [Abstract] [Full Text] [Related]

  • 34. Criteria for diagnosis of pure neural leprosy.
    Jardim MR, Antunes SL, Santos AR, Nascimento OJ, Nery JA, Sales AM, Illarramendi X, Duppre N, Chimelli L, Sampaio EP, Sarno EP.
    J Neurol; 2003 Jul; 250(7):806-9. PubMed ID: 12883921
    [Abstract] [Full Text] [Related]

  • 35. Therapeutic prospects for paucibacillary leprosy.
    Katoch K.
    Indian J Lepr; 2000 Jul; 72(3):351-61. PubMed ID: 11105276
    [No Abstract] [Full Text] [Related]

  • 36. Dapsone syndrome: an incomplete form.
    Jaswal R, Thami GP, Kanwar AJ.
    Indian J Lepr; 1998 Jul; 70(2):229-30. PubMed ID: 9724867
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
    Torres P, Camarena JJ, Gomez JR, Nogueira JM, Gimeno V, Navarro JC, Olmos A.
    Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
    [Abstract] [Full Text] [Related]

  • 38. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S, Somasiri KG, Chularatna W.
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [Abstract] [Full Text] [Related]

  • 39. Pure neuritic leprosy in India: an appraisal.
    Kumar B, Kaur I, Dogra S, Kumaran MS.
    Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):284-90. PubMed ID: 15485285
    [Abstract] [Full Text] [Related]

  • 40. Leprosy type 1 reaction as the first manifestation of borderline lepromatous leprosy in a young native German.
    Biedermann T, Degitz K, Schirren CG, Burgdorf W, Plewig G, Bieber T.
    Br J Dermatol; 1997 Dec; 137(6):1006-10. PubMed ID: 9470925
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.